Phase III study of N, N-Diethyl-2-[4-(Phenylmethyl) Phenoxyl] Ethanamine (BMS-2173801-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA-19

L. Reyno; L. Seymour; D. Tu; S. Dent; K. Gelmon; B. Walley; A. Pluzanska; V. Gorbunova; A. Garin; J. Jassem; T. Pienkowski; J. Dancey; L. Pearce; M. MacNeil; S. Marlin; D. Lebwohl; M. Voi; K. Pritchard; Gavin M. Marx; Josie J. Rutovitz

doi:10.1080/14733400410001728456

Phase III study of N, N-Diethyl-2-[4-(Phenylmethyl) Phenoxyl] Ethanamine (BMS-2173801-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA-19

L. Reyno, L. Seymour, D. Tu, S. Dent, K. Gelmon, B. Walley, A. Pluzanska, V. Gorbunova, A. Garin, J. Jassem, T. Pienkowski, J. Dancey, L. Pearce, M. MacNeil, S. Marlin, D. Lebwohl, M. Voi, K. Pritchard, Gavin M. Marx, Josie J. Rutovitz

Medicine

Medicine

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

Idioma original	English
Páginas (desde-hasta)	133-134
Número de páginas	2
Publicación	Women's Oncology Review
Volumen	4
N.º	2
DOI	https://doi.org/10.1080/14733400410001728456
Estado	Published - jun. 2004

ASJC Scopus Subject Areas

Oncology
Obstetrics and Gynaecology
Cancer Research

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1080/14733400410001728456

Otros archivos y enlaces

Citar esto

Reyno, L., Seymour, L., Tu, D., Dent, S., Gelmon, K., Walley, B., Pluzanska, A., Gorbunova, V., Garin, A., Jassem, J., Pienkowski, T., Dancey, J., Pearce, L., MacNeil, M., Marlin, S., Lebwohl, D., Voi, M., Pritchard, K., Marx, G. M., & Rutovitz, J. J. (2004). Phase III study of N, N-Diethyl-2-[4-(Phenylmethyl) Phenoxyl] Ethanamine (BMS-2173801-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA-19. Women's Oncology Review, 4(2), 133-134. https://doi.org/10.1080/14733400410001728456

Phase III study of N, N-Diethyl-2-[4-(Phenylmethyl) Phenoxyl] Ethanamine (BMS-2173801-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA-19. / Reyno, L.; Seymour, L.; Tu, D. et al.
En: Women's Oncology Review, Vol. 4, N.º 2, 06.2004, p. 133-134.

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

Reyno, L, Seymour, L, Tu, D, Dent, S, Gelmon, K, Walley, B, Pluzanska, A, Gorbunova, V, Garin, A, Jassem, J, Pienkowski, T, Dancey, J, Pearce, L, MacNeil, M, Marlin, S, Lebwohl, D, Voi, M, Pritchard, K, Marx, GM & Rutovitz, JJ 2004, 'Phase III study of N, N-Diethyl-2-[4-(Phenylmethyl) Phenoxyl] Ethanamine (BMS-2173801-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA-19', Women's Oncology Review, vol. 4, n.º 2, pp. 133-134. https://doi.org/10.1080/14733400410001728456

Reyno L, Seymour L, Tu D, Dent S, Gelmon K, Walley B et al. Phase III study of N, N-Diethyl-2-[4-(Phenylmethyl) Phenoxyl] Ethanamine (BMS-2173801-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA-19. Women's Oncology Review. 2004 jun.;4(2):133-134. doi: 10.1080/14733400410001728456

@article{947c7a880f8b497ea2a5348f8585fcb9,

title = "Phase III study of N, N-Diethyl-2-[4-(Phenylmethyl) Phenoxyl] Ethanamine (BMS-2173801-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA-19",

author = "L. Reyno and L. Seymour and D. Tu and S. Dent and K. Gelmon and B. Walley and A. Pluzanska and V. Gorbunova and A. Garin and J. Jassem and T. Pienkowski and J. Dancey and L. Pearce and M. MacNeil and S. Marlin and D. Lebwohl and M. Voi and K. Pritchard and Marx, {Gavin M.} and Rutovitz, {Josie J.}",

year = "2004",

month = jun,

doi = "10.1080/14733400410001728456",

language = "English",

volume = "4",

pages = "133--134",

journal = "Women's Oncology Review",

issn = "1473-3404",

publisher = "Parthenon Publishing Group",

number = "2",

}

TY - JOUR

T1 - Phase III study of N, N-Diethyl-2-[4-(Phenylmethyl) Phenoxyl] Ethanamine (BMS-2173801-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer

T2 - National Cancer Institute of Canada Clinical Trials Group Study MA-19

AU - Reyno, L.

AU - Seymour, L.

AU - Tu, D.

AU - Dent, S.

AU - Gelmon, K.

AU - Walley, B.

AU - Pluzanska, A.

AU - Gorbunova, V.

AU - Garin, A.

AU - Jassem, J.

AU - Pienkowski, T.

AU - Dancey, J.

AU - Pearce, L.

AU - MacNeil, M.

AU - Marlin, S.

AU - Lebwohl, D.

AU - Voi, M.

AU - Pritchard, K.

AU - Marx, Gavin M.

AU - Rutovitz, Josie J.

PY - 2004/6

Y1 - 2004/6

UR - http://www.scopus.com/inward/record.url?scp=4644369330&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=4644369330&partnerID=8YFLogxK

U2 - 10.1080/14733400410001728456

DO - 10.1080/14733400410001728456

M3 - Article

AN - SCOPUS:4644369330

SN - 1473-3404

VL - 4

SP - 133

EP - 134

JO - Women's Oncology Review

JF - Women's Oncology Review

IS - 2

ER -